Skip to content

OWLT

Owlet, Inc.

NYSE · USHealthcareMedical - Devices
$5.64+0.71%

Price as of Jul 20, 2026

OWLT growth

Owlet, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+26.8%
EBITDA
EBIT
+35.2%
EPS
Free cash flow
+23.6%
Operating cash flow
+28.0%

Forward estimates

Revenue
+33.4%
EBITDA
-52.1%
EPS
+99.7%

Three-year CAGR

Revenue
+15.2%
EBITDA
EBIT
+59.1%
Net income
EPS
Free cash flow
+7.6%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.